Taken together, these studies establish that DNA methylation of individual genes such as GSTP1, APC, or ZNF660, and, more effectively, multi-gene panels can provide clinically relevant information for PCa diagnosis, recurrence prediction, and risk stratification. The gene discussed is GSTP1; the disease is posterior cortical atrophy.